Metrikler
Yayın
5
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (5)
SCI-E, SSCI, AHCI (2)
SCI-E, SSCI, AHCI, ESCI (5)
ESCI (3)
Scopus (2)
2024
20241. ABCA4 variant screening in a Turkish cohort with Stargardt disease
KAHRAMAN N. S., Ozguc caliskan B., Kandemir N., Oner A., DÜNDAR M., ÖZKUL Y.
OPHTHALMIC GENETICS
, cilt.45, sa.2, ss.133-139, 2024 (SCI-Expanded, Scopus)
2022
20222. Evaluation of Utilizing the Distinct Genes as Predictive Biomarkers in Late-Onset Alzheimer's Disease
Kenanoglu S., KANDEMİR N., AKALIN H., GÖKÇE N., GÖL M. F., GÜLTEKİN M., et al.
GLOBAL MEDICAL GENETICS
, cilt.09, sa.02, ss.110-117, 2022 (ESCI)
2022
20223. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium
DÜNDAR M., FAHRİOGLU U., Yildiz S. H., Bakir-Gungor B., TEMEL Ş. G., AKIN H., et al.
FUNCTIONAL & INTEGRATIVE GENOMICS
, cilt.22, sa.3, ss.291-315, 2022 (SCI-Expanded, Scopus)
2021
20214. Propranolol significantly reduced DNA polymerase beta expression in patients with essential tremor
Kandemir N., Kenanoglu S., GÜLTEKİN M., GÖKÇE N., Akalin H., Tascioglu N., et al.
UNIVERSA MEDICINA
, cilt.40, sa.3, ss.207-215, 2021 (ESCI)
2020
20205. Propranolol decreases DRD3 and SLC1A2 gene expression in patients with essential tremor
KANDEMİR N., GÜLTEKİN M., Kara M., Bayram A., TAŞÇIOĞLU N., MİRZA M., et al.
UNIVERSA MEDICINA
, cilt.39, sa.2, ss.105-112, 2020 (ESCI)